Peripheral blood NK cells can be briefly activated with IL-12, IL-15 and IL-18 to induce differentiation into memory-like NK cells, associated with enhanced responses when simulated through tumor targets for weeks to months after pre-activation (14, 15). This evidence concerns the gene IL15 and neoplasm.